Cargando…
CD133 mediates the TGF-β1-induced activation of the PI3K/ERK/P70S6K signaling pathway in gastric cancer cells
Cluster of differentiation (CD)133 has been reported to be involved in the activation of the extracellular signal-regulated kinase (ERK) signaling pathway in different types of cancer cells. CD133 has been reported to be involved in the activation of the ERK signaling pathway in various cancer cells...
Autores principales: | Zhu, Youlong, Kong, Feifei, Zhang, Caihua, Ma, Cheng, Xia, Hong, Quan, Bin, Cui, Huaixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754832/ https://www.ncbi.nlm.nih.gov/pubmed/29344155 http://dx.doi.org/10.3892/ol.2017.7163 |
Ejemplares similares
-
Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133(+) Cell Populations and Suppressing ERK/P70S6K Signaling
por: Chai, Xinqun, et al.
Publicado: (2015) -
Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting
PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer
Cells
por: Lu, Ruiqi, et al.
Publicado: (2019) -
TGFβ activates PI3K-AKT signaling via TRAF6
por: Song, Jie, et al.
Publicado: (2017) -
Sensing and Integration of Erk and PI3K Signals by Myc
por: Lee, Tae, et al.
Publicado: (2008) -
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
por: Saito, Shigeki, et al.
Publicado: (2017)